Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
Gold continues to fall in global marketsUS Strikes Expand in Iran: 'Rain of Fire'Glenn Close and Ridley Scott to Receive Honorary OscarsNetanyahu to run again in upcoming electionsRussian court confirms sentence for Armenian bloggerIncentives in the Great Return programRussian ambassador returns to YerevanTrump: Erdoğan is my very good friendIAEA adopts resolution against IranAraz Nasirov leaves his post at TABIBGold continues to fall in global marketsUS Strikes Expand in Iran: 'Rain of Fire'Glenn Close and Ridley Scott to Receive Honorary OscarsNetanyahu to run again in upcoming electionsRussian court confirms sentence for Armenian bloggerIncentives in the Great Return programRussian ambassador returns to YerevanTrump: Erdoğan is my very good friendIAEA adopts resolution against IranAraz Nasirov leaves his post at TABIB
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU

#eli-lilly

Latest news and interesting information about eli-lilly.

Lilly to buy 3 vaccine developers for up to $3.83B
2026-05-26 11:01
|
736

Lilly to buy 3 vaccine developers for up to $3.83B

Eli Lilly acquires three vaccine developers: Curevo, LimmaTech, and Vaccine Company, for up to $3.83 billion to boost infectious disease R&D.

COMPANY →
0
Leerink Reaffirms Eli Lilly Stock Rating on Gene Therapy
2026-05-26 08:00
|
677

Leerink Reaffirms Eli Lilly Stock Rating on Gene Therapy

Leerink reaffirms Eli Lilly stock rating with Outperform and $1,119 target, citing promising gene therapy data from VERVE-102 trial. Bond.az covers the latest.

ANALYST RATINGS →
0
Novo, Lilly weight-loss pills lure patients from compounded drugs
2026-05-21 10:22
|
299

Novo, Lilly weight-loss pills lure patients from compounded drugs

Lower prices for Novo Nordisk and Eli Lilly weight-loss pills are driving patients from compounded drugs to branded Wegovy and Foundayo, according to doctors.

STOCK MARKETS →
0
...